Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
IO Biotech Announces Participation in Upcoming Investor Conferences
-
Local Bounti to Release Third Quarter 2024 Financial Results on Thursday, November 14, 2024
-
Nevro Reports Third-Quarter 2024 Financial Results
-
Zeta Accelerates Revenue Growth to 42% and Achieves the “Rule of 60” in 3Q’24
-
Bond Vet Unleashes AI-Driven Data Technology with Domo to Stay Ahead of the Pack
-
Gritstone bio Announces Strengthening of Maturing Phase 2 PFS Data for GRANITE Study and Provides Business Update
-
Intevac Announces Third Quarter 2024 Financial Results
-
Zillow Group to present at RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference
-
Quince Therapeutics Presents Safety Data from Prior Phase 3 ATTeST Clinical Trial at 53rd Child Neurology Society Annual Meeting
-
LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints
-
Invizyne Technologies Announces Pricing of $15 Million Initial Public Offering
-
Sonendo, Inc. to Release Third Quarter 2024 Financial Results and Postpone Conference Call on November 12, 2024
-
Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Monday, November 18, 2024
-
Bitfarms Reschedules Third Quarter 2024 Conference Call to November 13th, 2024
-
HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker
-
Nature’s Sunshine Appoints Steven Fasching to Board of Directors
-
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date October 31, 2024
-
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
CSX Executive Vice President and Chief Commercial Officer to Address Stephens Annual Investment Conference
-
Varonis to Present at Upcoming Investor Conferences
-
Robinhood Markets, Inc. Reports October 2024 Operating Data
-
DoubleDown Interactive Reports Third Quarter 2024 Financial Results
-
Nanox to Report Third Quarter and Financial Results on November 21, 2024
-
Crinetics Pharmaceuticals Announces November 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Regeneron Announces Investor Conference Presentations
-
Coterra Energy to Participate at Upcoming Conference
-
Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference
-
Revolutionizing Cryptocurrency Trading with Predictive AI: Meet with Nova Club
-
Standard Motor Products Broadens Collision Repair Program
-
Assertio Reports Third Quarter 2024 Financial Results
-
Intevac Announces Appointment of Ryan L. Vardeman to Board of Directors
-
Stereotaxis Reports 2024 Third Quarter Financial Results
-
Canadian Securities Exchange Welcomes Listing of Dunbar Metals Corp.
-
Update on Micromem's ARTRA Unit
-
Neurogene Reports Positive Interim Efficacy Data from First Four Low-Dose Pediatric Participants in NGN-401 Gene Therapy Clinical Trial for Rett Syndrome
-
Bicara Therapeutics to Present at the Stifel 2024 Healthcare Conference
-
Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial
-
Kura Sushi USA Announces Launch of Public Offering of Common Stock
-
Franklin Resources, Inc. Announces Month-End Assets Under Management
-
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Motorsport Games to Report Third Quarter 2024 Financial Results
-
Celldex Therapeutics to Present at Upcoming Investor Conferences
-
The Royal Canadian Legion hosts Canada’s 2024 National Remembrance Day Ceremony
-
A New Simple Way to Add Gift Ideas to Giftster Wish Lists - for All Four Leading Web Browsers
-
Following Trump Win, Harbour Investment Partners Launches Initiative to Help Savers Secure Competitive Rates as Interest Rates Predicted to Fall
-
Alkermes to Participate in Two Upcoming Investor Conferences
-
Great Choice for Trolling Motors Power the Adventures with Power Queen 12V 280Ah Low-Temp Deep Cycle Lithium Battery
-
Luminar Expands Business with Two Global Automakers and Reports Third Quarter 2024 Business Update
-
Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference
-
Following Trump Win, Harbour Investment Partners Launches Initiative to Help Savers Secure Competitive Rates as Interest Rates Predicted to Fall

